Bizu Gelaye1, Michelle A Williams2, Seblewengel Lemma3, Yemane Berhane3, Jesse R Fann4, Ann Vander Stoep5, Xiao-Hua Andrew Zhou6. 1. Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA; Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, USA. Electronic address: bgelaye@hsph.harvard.edu. 2. Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA. 3. Addis Continental Institute of Public Health, Addis Ababa, Ethiopia. 4. Department of Psychiatry and Behavioral Sciences, Rehabilitation Medicine, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA. 5. Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, USA. 6. Department of Biostatistics, University of Washington School of Public Health, Seattle, WA, USA.
Abstract
OBJECTIVE: We sought to evaluate the extent to which major depressive disorder (MDD) is associated with cardiometabolic diseases and risk factors. METHODS: This was a cross-sectional epidemiologic study of 1924 employed adults in Ethiopia. Structured interview was used to collect sociodemographic data, behavioral characteristics and MDD symptoms using a validated Patient Health Questionnaire-9 (PHQ-9) depression scale. Fasting blood glucose, insulin, C-reactive protein, and lipid concentrations were measured using standard approaches. Multivariate logistic regression models were fitted to estimate odds ratios (OR) and 95% confidence intervals (95% CI). RESULTS: A total of 154 participants screened positive for MDD on PHQ-9 (8.0%; 95% CI: 6.7-9.2%). Among women, MDD was associated with more than 4-fold increased odds of diabetes (OR=4.14; 95% CI: 1.03-16.62). Among men the association was not significant (OR=1.12; 95% CI: 0.63-1.99). Similarly, MDD was not associated with metabolic syndrome among women (OR=1.51; 95% CI: 0.69-3.29) and men (OR=0.61; 95% CI: 0.28-1.34). Lastly, MDD was not associated with increased odds of systemic inflammation. CONCLUSION: The results of our study do not provide convincing evidence that MDD is associated with cardiometabolic diseases among Ethiopian adults. Future studies need to evaluate the effect of other psychiatric disorders on cardiometabolic disease risk.
OBJECTIVE: We sought to evaluate the extent to which major depressive disorder (MDD) is associated with cardiometabolic diseases and risk factors. METHODS: This was a cross-sectional epidemiologic study of 1924 employed adults in Ethiopia. Structured interview was used to collect sociodemographic data, behavioral characteristics and MDD symptoms using a validated Patient Health Questionnaire-9 (PHQ-9) depression scale. Fasting blood glucose, insulin, C-reactive protein, and lipid concentrations were measured using standard approaches. Multivariate logistic regression models were fitted to estimate odds ratios (OR) and 95% confidence intervals (95% CI). RESULTS: A total of 154 participants screened positive for MDD on PHQ-9 (8.0%; 95% CI: 6.7-9.2%). Among women, MDD was associated with more than 4-fold increased odds of diabetes (OR=4.14; 95% CI: 1.03-16.62). Among men the association was not significant (OR=1.12; 95% CI: 0.63-1.99). Similarly, MDD was not associated with metabolic syndrome among women (OR=1.51; 95% CI: 0.69-3.29) and men (OR=0.61; 95% CI: 0.28-1.34). Lastly, MDD was not associated with increased odds of systemic inflammation. CONCLUSION: The results of our study do not provide convincing evidence that MDD is associated with cardiometabolic diseases among Ethiopian adults. Future studies need to evaluate the effect of other psychiatric disorders on cardiometabolic disease risk.
Authors: Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He Journal: Lancet Date: 2005 Jan 15-21 Impact factor: 79.321
Authors: Nicole Vogelzangs; Aartjan T F Beekman; Ingrid G Boelhouwer; Stefania Bandinelli; Yuri Milaneschi; Luigi Ferrucci; Brenda W J H Penninx Journal: J Clin Psychiatry Date: 2011-04-05 Impact factor: 4.384
Authors: Anne Herva; Pirkko Räsänen; Jouko Miettunen; Markku Timonen; Kristian Läksy; Juha Veijola; Jaana Laitinen; Aimo Ruokonen; Matti Joukamaa Journal: Psychosom Med Date: 2006 Mar-Apr Impact factor: 4.312
Authors: Lissa N Mandell; Manasi S Parrish; Violeta J Rodriguez; Maria L Alcaide; Stephen M Weiss; Karl Peltzer; Deborah L Jones Journal: AIDS Behav Date: 2021-10-14
Authors: Davy Vancampfort; Brendon Stubbs; Marc De Hert; Christy du Plessis; Caleb Ademola Omuwa Gbiri; Jepkemoi Kibet; Nancy Wanyonyi; James Mugisha Journal: Pan Afr Med J Date: 2017-02-28
Authors: Ben Brinkmann; Collin F Payne; Iliana Kohler; Guy Harling; Justine Davies; Miles Witham; Mark J Siedner; Ali Sie; Mamadou Bountogo; Lucienne Ouermi; Boubacar Coulibaly; Till Bärnighausen Journal: BMJ Open Date: 2020-12-22 Impact factor: 2.692